A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications.


Journal

Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 14 2 2019
medline: 13 3 2020
entrez: 14 2 2019
Statut: ppublish

Résumé

In line with the recent global action plan for antimicrobial resistance, this is the first time such a comprehensive antimicrobial point prevalence survey has been undertaken in Pakistan, the sixth most populous country. This point prevalence survey (PPS) was conducted in 13 hospitals among 7 different cities of Pakistan. The survey included all inpatients receiving an antibiotic on the day of PPS. A web-based application was used for data entry, validation, and reporting as designed by the University of Antwerp (www.global-pps.com). Out of 1954 patients, 1516 (77.6%) were treated with antibiotics. The top three most reported indications for antibiotic use were prophylaxis for obstetrics or gynaecological indications (16.5%), gastrointestinal indications (12.6%) and lower respiratory tract infections (12.0%). The top three most commonly prescribed antibiotics were ceftriaxone (35.0%), metronidazole (16.0%) and ciprofloxacin (6.0%). Out of the total indications, 34.2% of antibiotics were prescribed for community-acquired infections (CAI), 5.9% for healthcare-associated infections (HAI), and 57.4% for either surgical or medical prophylaxis. Of the total use for surgical prophylaxis, 97.4% of antibiotics were given for more than one day. Unnecessary prophylactic antibiotic use is extremely high, and broad-spectrum prescribing is common among hospitals in Pakistan. There is an urgent need to work on the  national action plan of Pakistan on antibiotic resistance to address this.

Identifiants

pubmed: 30755077
doi: 10.1080/14787210.2019.1581063
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-293

Auteurs

Zikria Saleem (Z)

a School of Pharmaceutical Sciences , Universiti Sains Malaysia , Penang , Malaysia.
b Department of Pharmacy Practice , Rashid Latif College of Pharmacy , Pakistan.

Mohamed Azmi Hassali (MA)

a School of Pharmaceutical Sciences , Universiti Sains Malaysia , Penang , Malaysia.

Ann Versporten (A)

c Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences , University of Antwerp , Antwerp , Belgium.

Brian Godman (B)

d Department of Clinical Pharmacology , Karolinska Institute , Stockholm , Sweden.
e Strathclyde Institute of Pharmacy and Biomedical Sciences , Strathclyde University , Glasgow , UK.
f Health Economics Centre , University of Liverpool Management School , Liverpool , UK.

Furqan Khurshid Hashmi (FK)

g Department of Pharmacy Practice , University College of Pharmacy, University of the Punjab , Lahore , Pakistan.

Herman Goossens (H)

c Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences , University of Antwerp , Antwerp , Belgium.

Fahad Saleem (F)

h Faculty of Pharmacy and Health sciences , University of Balochistan , Quetta , Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH